Results 141 to 150 of about 8,385,421 (296)

Efficacy, Safety and Biological Characteristics of Formulation Based on Essential Oil Against Co‐Infections of Herpes Simplex Virus‐1 and Candida albicans

open access: yesMicrobiologyOpen, Volume 15, Issue 1, February 2026.
Essential oils with anti‐HSV‐1 activity were identified through literature review and tested against Candida to develop a formulation for co‐infections. The blend was assessed for anti‐inflammatory properties, allergenic potential via standardized BAT, and overall antiviral efficacy.
Maura Di Vito   +11 more
wiley   +1 more source

Tumor Immunotherapy and Microbiome: From Bench‐to‐Bedside Applications

open access: yesMedComm, Volume 7, Issue 2, February 2026.
The microbiome is related to the efficacy of immunotherapy and can be utilized to predict the efficacy and adverse reactions of immunotherapy. Microbiome‐targeted intervention strategies can improve the efficacy of ICI, but necessitating more comprehensive exploration.
Anqi Lin   +12 more
wiley   +1 more source

HHV-6 and Multiple Sclerosis

open access: yes, 2014
Multiple sclerosis (MS) is an inflammatory demyelinating disease affecting the central nervous system, thought to be an autoimmune disease mediated by autoreactive lymphocytes. The pathogenesis of MS is multifactorial and is thought to be triggered by multiple environmental factors in genetically susceptible individuals.
Jeanne Billioux, Bridgette   +2 more
openaire   +1 more source

Ischemic Stroke in Hypereosinophilic Syndrome: A Clinicopathologic Study of Two Cases

open access: yesNeuropathology, Volume 46, Issue 1, February 2026.
ABSTRACT Ischemic stroke is a rare complication of hypereosinophilic syndrome (HES). Manifestations of stroke in HES have been described in the radiologic literature; however the pathologic characterization of central nervous system (CNS) involvement in HES is limited.
Karina C. Martin   +3 more
wiley   +1 more source

Association of human herpesvirus-6B with mesial temporal lobe epilepsy.

open access: yesPLoS Medicine, 2007
BackgroundHuman herpesvirus-6 (HHV-6) is a beta-herpesvirus with 90% seroprevalence that infects and establishes latency in the central nervous system. Two HHV-6 variants are known: HHV-6A and HHV-6B.
Julie Fotheringham   +12 more
doaj   +1 more source

An impact of activated Epstein–Barr Virus and HHV-6 on the course and control of bronchial asthma in children of the Amur Region

open access: diamond, 2022
Е. N. Suprun   +5 more
openalex   +2 more sources

減圧ストレスと疲労の関係 [PDF]

open access: yes, 2016
埼玉医科大学平成28年
望月 徹
core  

Post‐Varicella Purpura Fulminans With Extensive Skin Necrosis in a Child

open access: yes
eJHaem, Volume 7, Issue 1, February 2026.
Madalena Correia Pires   +5 more
wiley   +1 more source

Human Herpesvirus 6 Activates NF-κB Signalling and CD163-Positive Macrophage Recruitment in Alcohol-Induced Hepatic Injury

open access: yesMicroorganisms
Human herpesvirus 6 (HHV-6) establishes lifelong latency in immune cells and may contribute to the progression of ethanol-induced liver injury. To elucidate the contribution of HHV-6 to alcohol-induced hepatic injury, this study evaluated HHV-6 protein ...
Anda Upane   +3 more
doaj   +1 more source

HHV-6 meningoencephalitis in an immunocompetent patient with influenza virus co-infection

open access: gold, 2021
R. Jiménez Bolaños   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy